Marex Group’s 10x Genomics TXG Stock Holding History

Marex Group’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$758K	Buy	35,711 +6,310	+21%	+$126K	﹤0.01%	508
2025 Q4	$480K	Buy	+29,401	New	+$444K	﹤0.01%	577

Other funds holding TXG

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

QCM

Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marex Group's TXG Position: Q1 2026 in Review

Marex Group increased its 10x Genomics (TXG) stake by 21% in Q1 2026, buying an estimated $126K and bringing the position to 35,711 shares worth $758K. The position accounts for ﹤0.01% of the portfolio, ranked #508.

Marex Group first reported a position in TXG in Q4 2025 and has held it in 2 quarters since. 329 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

Marex Group held 35,711 shares of 10x Genomics worth $758K as of Q1 2026.
Marex Group bought 6,310 10x Genomics shares in Q1 2026, an estimated $126K.
10x Genomics made up ﹤0.01% of Marex Group's portfolio in Q1 2026, its #508 holding.
Marex Group first reported a position in 10x Genomics in Q4 2025 and has held it in 2 quarters since.
329 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on Marex Group's 13F filing for Q1 2026, filed 13 May 2026.